Bosera Hang Seng Healthcare ETF (QDII) (SHA:513060)
China · Delayed Price · Currency is CNY 0.6710
-0.0190 (-2.75%)
At close: Oct 17, 2025
-2.75% (1Y)
| Assets | 7.04B |
| Expense Ratio | 0.65% |
| PE Ratio | 12.80 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +65.27% |
| Volume | 1,752,136,000 |
| Open | 0.6930 |
| Previous Close | 0.6900 |
| Day's Range | 0.6690 - 0.6930 |
| 52-Week Low | 0.3620 |
| 52-Week High | 0.7640 |
| Beta | n/a |
| Holdings | 71 |
| Inception Date | Mar 18, 2021 |
About 513060
513060.SS was created on 2021-03-18 by Bosera. The fund's investment portfolio concentrates primarily on health care equity. Closely track underlying index,Tightly track the target and minimize the deviation
Asset Class Equity
Category Health Care
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 513060
Provider Bosera
Index Tracked Hang Seng Healthcare Index - CNY - Benchmark TR Gross
Performance
513060 had a total return of 65.27% in the past year, including dividends. Since the fund's inception, the average annual return has been -8.29%.
Top 10 Holdings
57.04% of assets| Name | Symbol | Weight |
|---|---|---|
| Innovent Biologics, Inc. | 1801 | 10.19% |
| BeOne Medicines AG | 6160 | 8.96% |
| WuXi Biologics (Cayman) Inc. | 2269 | 8.31% |
| CSPC Pharmaceutical Group Limited | 1093 | 5.45% |
| Akeso, Inc. | 9926 | 5.42% |
| Sino Biopharmaceutical Limited | 1177 | 4.76% |
| JD Health International Inc. | 6618 | 4.22% |
| 3SBio Inc. | 1530 | 3.97% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 3.09% |
| Alibaba Health Information Technology Limited | 0241 | 2.67% |